Literature DB >> 12879072

Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels.

Hiroyuki Watanabe1, Joris Vriens, Jean Prenen, Guy Droogmans, Thomas Voets, Bernd Nilius.   

Abstract

TRPV4 is a widely expressed cation channel of the 'transient receptor potential' (TRP) family that is related to the vanilloid receptor VR1 (TRPV1). It functions as a Ca2+ entry channel and displays remarkable gating promiscuity by responding to both physical stimuli (cell swelling, innoxious heat) and the synthetic ligand 4alphaPDD. An endogenous ligand for this channel has not yet been identified. Here we show that the endocannabinoid anandamide and its metabolite arachidonic acid activate TRPV4 in an indirect way involving the cytochrome P450 epoxygenase-dependent formation of epoxyeicosatrienoic acids. Application of 5',6'-epoxyeicosatrienoic acid at submicromolar concentrations activates TRPV4 in a membrane-delimited manner and causes Ca2+ influx through TRPV4-like channels in vascular endothelial cells. Activation of TRPV4 in vascular endothelial cells might therefore contribute to the relaxant effects of endocannabinoids and their P450 epoxygenase-dependent metabolites on vascular tone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879072     DOI: 10.1038/nature01807

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  357 in total

1.  Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2+ entry and mitochondrial ROS signaling.

Authors:  Aaron H Bubolz; Suelhem A Mendoza; Xiaodong Zheng; Natalya S Zinkevich; Rongshan Li; David D Gutterman; David X Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

2.  Transient receptor potential ion channels V4 and A1 contribute to pancreatitis pain in mice.

Authors:  Eugene Ceppa; Fiore Cattaruzza; Victoria Lyo; Silvia Amadesi; Juan-Carlos Pelayo; Daniel P Poole; Natalya Vaksman; Wolfgang Liedtke; David M Cohen; Eileen F Grady; Nigel W Bunnett; Kimberly S Kirkwood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-10       Impact factor: 4.052

Review 3.  Vanilloid and melastatin transient receptor potential channels in vascular smooth muscle.

Authors:  Scott Earley
Journal:  Microcirculation       Date:  2010-05       Impact factor: 2.628

4.  5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.

Authors:  Magali Cazade; Isabelle Bidaud; Pernille B Hansen; Philippe Lory; Jean Chemin
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

5.  Hypotonic shocks activate rat TRPV4 in yeast in the absence of polyunsaturated fatty acids.

Authors:  Stephen H Loukin; Zhenwei Su; Ching Kung
Journal:  FEBS Lett       Date:  2009-01-25       Impact factor: 4.124

6.  Thermosensitive transient receptor potential (TRP) channel agonists and their role in mechanical, thermal and nociceptive sensations as assessed using animal models.

Authors:  A H Klein; Minh Trannyguen; Christopher L Joe; Carstens M Iodi; E Carstens
Journal:  Chemosens Percept       Date:  2015-08       Impact factor: 1.833

Review 7.  Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.

Authors:  Arthur A Spector; Hee-Yong Kim
Journal:  Biochim Biophys Acta       Date:  2014-08-02

8.  The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo.

Authors:  M S Grace; T Lieu; B Darby; F C Abogadie; N Veldhuis; N W Bunnett; P McIntyre
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 9.  Invertebrate TRP proteins as functional models for mammalian channels.

Authors:  Joris Vriens; Grzegorz Owsianik; Thomas Voets; Guy Droogmans; Bernd Nilius
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

Review 10.  Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.

Authors:  Armen N Akopian; Nikita B Ruparel; Nathaniel A Jeske; Amol Patwardhan; Kenneth M Hargreaves
Journal:  Trends Pharmacol Sci       Date:  2008-12-11       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.